Cargando…

RIG-1 receptor expression in the pathology of Alzheimer’s disease

BACKGROUND: Neuroinflammation plays a critical role in the pathogenesis of Alzheimer’s disease (AD) and involves activation of the innate immune response via recognition of diverse stimuli by pattern recognition receptors (PRRs). The inflammatory inducers and precise innate signaling pathway contrib...

Descripción completa

Detalles Bibliográficos
Autores principales: de Rivero Vaccari, Juan Pablo, Brand, Frank J, Sedaghat, Christina, Mash, Deborah C, Dietrich, W Dalton, Keane, Robert W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977677/
https://www.ncbi.nlm.nih.gov/pubmed/24694234
http://dx.doi.org/10.1186/1742-2094-11-67
_version_ 1782310454037577728
author de Rivero Vaccari, Juan Pablo
Brand, Frank J
Sedaghat, Christina
Mash, Deborah C
Dietrich, W Dalton
Keane, Robert W
author_facet de Rivero Vaccari, Juan Pablo
Brand, Frank J
Sedaghat, Christina
Mash, Deborah C
Dietrich, W Dalton
Keane, Robert W
author_sort de Rivero Vaccari, Juan Pablo
collection PubMed
description BACKGROUND: Neuroinflammation plays a critical role in the pathogenesis of Alzheimer’s disease (AD) and involves activation of the innate immune response via recognition of diverse stimuli by pattern recognition receptors (PRRs). The inflammatory inducers and precise innate signaling pathway contributing to AD pathology remain largely undefined. RESULTS: In the present study we analyzed expression levels of innate immune proteins in temporal and occipital cortices from preclinical (no cognitive impairment, NCI, N = 22) to mild cognitive impairment (MCI, N = 20) associated with AD pathology (N = 20) and AD patients (N = 23). We found that retinoic acid-inducible gene-I (RIG-1) is significantly elevated in the temporal cortex and plasma in patients with MCI. In addition, primary human astrocytes stimulated with the RIG-1 ligand 5′ppp RNA showed increased expression of amyloid precursor protein (APP) and amyloid-β (Aβ), supporting the idea that RIG-1 is involved in the pathology of MCI associated with early progression to AD. CONCLUSION: These findings suggest that RIG-1 may play a critical role in incipient AD.
format Online
Article
Text
id pubmed-3977677
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39776772014-04-08 RIG-1 receptor expression in the pathology of Alzheimer’s disease de Rivero Vaccari, Juan Pablo Brand, Frank J Sedaghat, Christina Mash, Deborah C Dietrich, W Dalton Keane, Robert W J Neuroinflammation Research BACKGROUND: Neuroinflammation plays a critical role in the pathogenesis of Alzheimer’s disease (AD) and involves activation of the innate immune response via recognition of diverse stimuli by pattern recognition receptors (PRRs). The inflammatory inducers and precise innate signaling pathway contributing to AD pathology remain largely undefined. RESULTS: In the present study we analyzed expression levels of innate immune proteins in temporal and occipital cortices from preclinical (no cognitive impairment, NCI, N = 22) to mild cognitive impairment (MCI, N = 20) associated with AD pathology (N = 20) and AD patients (N = 23). We found that retinoic acid-inducible gene-I (RIG-1) is significantly elevated in the temporal cortex and plasma in patients with MCI. In addition, primary human astrocytes stimulated with the RIG-1 ligand 5′ppp RNA showed increased expression of amyloid precursor protein (APP) and amyloid-β (Aβ), supporting the idea that RIG-1 is involved in the pathology of MCI associated with early progression to AD. CONCLUSION: These findings suggest that RIG-1 may play a critical role in incipient AD. BioMed Central 2014-04-02 /pmc/articles/PMC3977677/ /pubmed/24694234 http://dx.doi.org/10.1186/1742-2094-11-67 Text en Copyright © 2014 de Rivero Vaccari et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
de Rivero Vaccari, Juan Pablo
Brand, Frank J
Sedaghat, Christina
Mash, Deborah C
Dietrich, W Dalton
Keane, Robert W
RIG-1 receptor expression in the pathology of Alzheimer’s disease
title RIG-1 receptor expression in the pathology of Alzheimer’s disease
title_full RIG-1 receptor expression in the pathology of Alzheimer’s disease
title_fullStr RIG-1 receptor expression in the pathology of Alzheimer’s disease
title_full_unstemmed RIG-1 receptor expression in the pathology of Alzheimer’s disease
title_short RIG-1 receptor expression in the pathology of Alzheimer’s disease
title_sort rig-1 receptor expression in the pathology of alzheimer’s disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977677/
https://www.ncbi.nlm.nih.gov/pubmed/24694234
http://dx.doi.org/10.1186/1742-2094-11-67
work_keys_str_mv AT deriverovaccarijuanpablo rig1receptorexpressioninthepathologyofalzheimersdisease
AT brandfrankj rig1receptorexpressioninthepathologyofalzheimersdisease
AT sedaghatchristina rig1receptorexpressioninthepathologyofalzheimersdisease
AT mashdeborahc rig1receptorexpressioninthepathologyofalzheimersdisease
AT dietrichwdalton rig1receptorexpressioninthepathologyofalzheimersdisease
AT keanerobertw rig1receptorexpressioninthepathologyofalzheimersdisease